PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2004 March; 5(1): 50–57.
Published online 2004 February 12. doi:  10.1208/pt050109
PMCID: PMC2784860

Effect of degree of esterification of pectin and calcium amount on drug release from pectin-based matrix tablets

Abstract

The aim of this work was to assess the effect of 2 formulation variables, the pectin type (with different degrees of esterification [DEs]) and the amount of calcium, on drug release from pectin-based matrix tablets. Pectin matrix tablets were prepared by blending indomethacin (a model drug), pectin powder, and various amounts of calcium acetate and then tableting by automatic hydraulic press machine. Differential scanning calorimetry, powder x-ray diffraction, and Fourier transformed-infrared spectroscopy studies of the compressed tablets revealed no drug-polymer interaction and the existence of drug with low crystallinity. The in-vitro release studies in phosphate buffer (United States Pharmacopeia) and tris buffer indicated that the lower the DE, the greater the time for 50% of drug release (T50). This finding is probably because of the increased binding capacity of pectin to calcium. However, when the calcium was excluded, the pectins with different DEs showed similar release pattern with insignificant difference of T50. When the amount of calcium acetate was increased from 0 to 12 mg/tablet, the drug release was significantly slower. However, a large amount of added calcium (ie, 24 mg/tablet) produced greater drug release because of the partial disintegration of tablets. The results were more pronounced in phosphate buffer, where the phosphate ions induced the precipitation of calcium phosphate. In conclusion, both pectin type and added calcium affect the drug release from the pectin-based matrix tablets.

Keywords: pectin, hydrogel matrices, matrix tablets, controlled-release, sustained-release, indomethacin

Full Text

The Full Text of this article is available as a PDF (868K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Kudela V. Hydrogels. In: Mark HF, Bikales N, Overberger CG, Menges G, Kroschwitz JI, editors. Encyclopedia of polymer Science and Engineering. New York, NY: John Wiley & Sons; 1987. pp. 703–807.
2. Graham NB, McNeill ME. Hydrogels for controlled drug delivery. Biomaterials. 1984;5:27–36. doi: 10.1016/0142-9612(84)90063-2. [PubMed] [Cross Ref]
3. Tiwari SB, Murthy TK, Pai MR, Mehta PR, Chowdary PB. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system.AAPS PharmSciTech. 2003;4(3): article 31. [PMC free article] [PubMed]
4. Krusteva S, Lambov N, Velinov G. Pharmaceutical investigation of a bioerodible nystatin system. Pharmazie. 1990;45:195–197. [PubMed]
5. Naggar VF, El-Khawas M, Ismail FA, Boraire NA. Pectin, a possible matrix for oral sustained release preparations of water-soluble drugs. STP Pharma Sci. 1992;2:227–234.
6. Sungthongjeen S, Pitaksuteepong T, Somsiri A, Sriamornsak P. Studies on pectins as potential hydrogel matrices for controlled-release drug delivery. Drug Dev Ind Pharm. 1999;25:1271–1276. doi: 10.1081/DDC-100102298. [PubMed] [Cross Ref]
7. Rolin C. Pectin. In: Whistler RL, Bemiller JN, editors. Industrial Gums: Polysaccharides and Their Derivatives. New York, NY: Academic Press; 1993. pp. 257–293.
8. Oakenfull DG. The chemistry of high-methoxy pectins. In: Walter RH, editor. The Chemistry and Technology of Pectin. New York, NY: Academic Press; 1991. pp. 87–108.
9. O'Brien M, McCauley J, Cohen J. Indomethacin. In: Florey K, editor. Analytical Profiles of Drug Substances. New York, NY: Academic Press; 1984. pp. 211–218.
10. Puttipipatkhachorn S, Mitrevej A, Papangkornkij V, Srivichitchok V. Variation in powder characteristics of indomethacin from various sources. Thai J Pharm Sci. 1993;17:5–11.
11. Ashford M, Fell T, Attwood D, Sharma H, Woodhead P. An evaluation of pectin as a carrier for drug targeting to colon. J Control Release. 1993;26:213–220. doi: 10.1016/0168-3659(93)90188-B. [Cross Ref]
12. Ashford M, Fell T, Attwood D, Sharma H, Woodhead P. Studies on pectin formulations for colonic drug delivery. J Control Release. 1994;30:225–232. doi: 10.1016/0168-3659(94)90028-0. [Cross Ref]
13. Sriamornsak P, Nunthanid J. Calcium pectinate gel beads for controlled release drug delivery: I. Preparation and in vitro release studies. Int J Pharm. 1998;160:207–212. doi: 10.1016/S0378-5173(97)00310-4. [Cross Ref]
14. Sriamornsak P. Investigation of pectin as a carrier for oral delivery of proteins using calcium pectinate gel beads. Int J Pharm. 1998;169:213–220. doi: 10.1016/S0378-5173(98)00129-X. [Cross Ref]
15. Ahrabi SF, Madsen G, Dyrstad K, Sande SA, Graffner C. Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. Eur J Pharm Sci. 2000;10:43–52. doi: 10.1016/S0928-0987(99)00087-1. [PubMed] [Cross Ref]
16. Sriamornsak P. Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins from calcium pectinate gel beads. Eur J Pharm Sci. 1999;8:221–227. doi: 10.1016/S0928-0987(99)00010-X. [PubMed] [Cross Ref]
17. Lindahl A, Ungell AL, Knutson L, Lennernas H. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res. 1997;14:497–502. doi: 10.1023/A:1012107801889. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists